I never thought I would make a post hoping that Cellmid didn't make sales but there is above.
I don't see COVID as a money making opportunity and certainly hope that any reliable vaccine candidate is shared openly and without restriction. Vulnerable people should come first.
Should a second wave arrive in Australia , ab POCTS can and should be used to cast a much wider (and more cost effective) net than PCRs alone. Again and again people in the know say that both test types need to complement each other.
As the flu season arrives, influenza POCTs should be used to quickly identify influenza patients so that they can be sent home for lemon tea treatment.
cheers
- Forums
- ASX - By Stock
- AN1
- Ann: Company Update
Ann: Company Update, page-60
-
- There are more pages in this discussion • 90 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable